Subcutaneous Biologics Market Forecast 2030: Emerging Trends

Postado 2025-10-30 07:21:14

Future Subcutaneous Biologics Market: Key Dynamics, Size & Share Analysis

The Global Subcutaneous Biologics Market size was valued at around USD 2.02 billion in 2024 and is projected to reach USD 4.11 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 11% during the forecast period, i.e., 2025-30. This growth is attributed to various factors like technological advancements coupled with strategies built for individual patients. Also, regulatory support from governments worldwide through various policies & incentives is helping in the market growth. Additionally, access to biologists is increasing with regulatory approvals like the FDA’s nod for Amgen’s biosimilar Amjevita in 2023.

Top Challenges Impacting the Subcutaneous Biologics Market Growth

Allergic Reactions & Device Issues in Subcutaneous Biologics – Side effects and allergic reactions are one of the most prominent issues for the global subcutaneous biologics industry. As these biologics are commonly made from proteins, they have the potential to trigger minor to severe allergic reactions by inciting an immunological response. Hypersensitivity response cases have been found in about 1-10% of the patients undergoing biologic treatments, as per the Journal of Allergy and Clinical Immunology. One of the important cases involved the monoclonal antibodies that could lead to infusion-related reactions like cytokine release syndrome. The need for monitoring and patient education has grown due to the 7% of patients experiencing injection site reactions as per studies on adalimumab biologics. Also, the major concerns are the long-term side effects, like increased risks of infections and malignancies. In addition, the occurrence of malfunctions and injuries due to a lack of AI capabilities in devices is rising, particularly in auto-injectors. Device problems, such as breakage, defects, jams, and others, accounted for 45% of incidents, while 10% are attributed to patient problems, particularly missed and underdoses.

In case you missed it, we are currently revising our reports. Click on the below to get the latest research data with forecast for years 2026 to 2032, including market size, industry trends, and competitive analysis. It wouldn’t take long for the team to deliver the most recent version of the report.

Unlock exclusive insights into the Subcutaneous Biologics– request your free sample PDF now and explore key trends, growth drivers, and competitive strategies shaping the industry- https://www.marknteladvisors.com/query/request-sample/subcutaneous-biologics-market.html

Understanding the Core Segments in the Subcutaneous Biologics Market

Subcutaneous Biologics Market Size, Share & Industry Trends Analysis- By Subcutaneous Drug Delivery System (Prefilled Syringe, Wearable Injectors, Auto-Injectors, Implants, Pen Injectors, Drug Reconstitution Delivery Systems), By Application (Crohn’s Disease, Rheumatoid Arthritis, Cancer, Leukaemia, Lymphoma, Psoriasis, Diabetes, Cardiovascular Disorder, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) and Others

Geographical Analysis of the Subcutaneous Biologics Market

North America
South America
Europe
The Middle East and Africa
Asia-Pacific

North America now has the majority market share in the subcutaneous biologics market all over the world.

Who Dominates the Subcutaneous Biologics Market Insights on Key Industry Players?

Companies are strengthening their presence in the Subcutaneous Biologics market by adopting strategies such as forming strategic alliances, leveraging AI, entering partnerships, pursuing mergers and acquisitions, expanding into new regions, and introducing innovative products and services.

AbbVie, Inc.
Hoffmann-La
Biogen Idec
Amgen, Inc.,
Pfizer Ltd.
Marcolin SpA
Bristol-Myers Squibb
Takeda Pharmaceutical Company Ltd.
Roche AG
Genentech Inc.
Eisai, Inc.
Novartis AG
Bayer AG
Abbott Laboratories
GlaxoSmithKline
Others

Tap into future trends and opportunities shaping the Subcutaneous Biologics Market View Full report: - https://www.marknteladvisors.com/research-library/subcutaneous-biologics-market.html

Why Choose This MarkNtel Advisors Research Report

Comprehensive Insights – Offers a 360° view of the market, combining qualitative and quantitative analysis for a deep understanding of trends, drivers, challenges, and opportunities.
Reliable Data Sources – Data is gathered through verified primary and secondary sources, ensuring accuracy and credibility.
Actionable Forecasts – Advanced predictive modeling and time-series analysis provide practical insights to guide strategic decisions and business planning.
Expert Analysis – Insights from industry experts help interpret complex market dynamics, delivering clarity beyond the numbers.
Customized & Strategic Reporting – The report includes detailed charts, graphs, and strategic recommendations tailored to support business growth and investment decisions.
Trusted Methodology – Built on rigorous research principles, including precise sampling, data validation, and forecasting techniques, reflecting the trust businesses place in MarkNtel Advisors.

"This report equips decision-makers with actionable intelligence, enabling them to navigate market complexities with confidence and foresight."

Gain exclusive access to our comprehensive insights on the Future of Subcutaneous Biologics Market. With tailored licensing options, including Mini Report Pack, Excel Data Pack, Single User, Multiuser, and Enterprise Packs, our research empowers organizations to navigate dynamic market trends effectively.

Select a License That Matches Your Business Requirements with Instant Offer - https://www.marknteladvisors.com/pricing/subcutaneous-biologics-market.html

About us:

MarkNtel Advisors is a distinguished Industry Research Report Firm and Market Research Company offering comprehensive intelligence across the healthcare sector, covering pharmaceuticals, medical devices, healthcare IT, and biotechnology. Our team delivers high-precision Market Research Reports and Business Analysis at global, regional, and country levels to help organizations understand market access strategies, innovation trends, and regulatory frameworks. Using robust data methodologies and validated Market Forecast models, we provide insights that enhance decision-making and operational agility. Our expertise extends to Customized Market Research Reports that measure therapeutic performance, digital transformation, and patient-centric solutions. Through strategic Consulting Services, we empower healthcare companies, investors, and policymakers to quantify Revenue Impact, strengthen competitiveness, and accelerate sustainable growth within the dynamic global healthcare landscape.

Other Reports: